Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
08 Jun 2020 - 12 Jun 2020

BIO 2020, San Diego (CA), US – Digital

03 May 2020 - 07 May 2020

2020 ARVO Annual Meeting, Baltimore (MD), US – cancelled

12 May 2020 - 15 May 2020

ASGCT 23rd Annual Meeting, Boston (MA), USA – Virtual Format

22 April 2020

GenSight Biologics will hold its General Meeting on April 29, 2020 behind closed doors

25 Apr 2020 - 01 May 2020

2020 AAN Annual Meeting, Toronto, Canada – canceled due to COVID-19

21 April 2020

GenSight Biologics Reports Cash Position as of March 31, 2020 and Provides Operational Update

15 April 2020

GenSight Biologics on Track to Submit LUMEVOQ® for European Approval in September 2020 Following Pre-Submission Meeting with EMA

14 April 2020

GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa

19 Apr 2020 - 21 Apr 2020

H.C. Wainwright Global Life Sciences Conference, London, UK – cancelled

08 April 2020

Annual General Meeting on April 29, 2020 Procedures for obtaining preparatory documents for the General Meeting

  • View previous 9 articles
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 42
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page